7.280USD+4.67%Mkt Cap: 374.29M USDP/E: —Last update: 2026-06-01
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Techn…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap374.29M USD
Enterprise Value461.34M USD
Revenue (TTM)87.82M USD
Gross Profit150.14M USD
Net Income (TTM)-193.88M USD
Revenue/Share1.694 USD
Last Price7.280 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees371
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS75901B1070
Valuation
P/E (Trailing)—
P/E (Forward)-2.78
PEG—
EV/EBITDA-1.91
EV/Revenue5.25
P/S4.13
P/B17.18
EPS (TTM)-5.60
EPS (Forward)-2.52
52W Range
5.45517% of range16.19
52W High16.19 USD
52W Low5.455 USD
Profitability
Gross Margin88.09%
Oper. Margin-1303.96%
EBITDA Margin-274.61%
Profit Margin-113.75%
ROE-188.72%
ROA-42.80%
Growth
Revenue Growth-92.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-123.96M USD
CapEx (TTM)2.41M USD
FCF Margin-158.25%
FCF Yield-37.13%
Net Debt97.90M USD
Net Debt/EBITDA-0.41
Balance Sheet
Debt/Equity0.72
Current Ratio2.62
Quick Ratio2.44
Book Value/Sh0.4080 USD
Cash/Share2.911 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)24.18 USD
Target Range10.00 USD – 50.00 USD
# Analysts11
Ownership
Shares Out.51.70M
Float43.10M
Insiders7.78%
Institutions84.78%
Short Interest
Short Ratio5.2d
Short % Float14.85%
Short % Out.13.80%
Shares Short7.14M
Short (prev mo.)6.94M
Technical
SMA 508.394 (-13.3%)
SMA 20010.48 (-30.5%)
Beta1.12
S&P 52W Chg27.70%
Avg Vol (30d)1.53M
Avg Vol (10d)2.11M
Technical Indicators
RSI (14)42.5
MACD-0.6856
MACD Signal-0.6169
MACD Hist.-0.0687
BB Upper11.76 USD
BB Middle7.919 USD
BB Lower4.076 USD
BB Width97.06%
ATR (14)0.6553 USD
Vol Ratio (20d)0.36x